HAI
TEVA icon

Hennessy Advisors Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Hennessy Advisors Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-652,100
Closed -$10M – 383
2025
Q1 		$10M Sell
652,100
-74,500
-10% -$1.33M 0.33% 81
2024
Q4 		$16M Buy
726,600
+46,300
+7% +$842K 0.48% 51
2024
Q3 		$12.3M Buy
680,300
+76,400
+13% +$1.34M 0.39% 59
2024
Q2 		$9.81M Buy
+603,900
New +$9.3M 0.37% 60
2018
Q1 		– Sell
-147,300
Closed -$2.79M – 419
2017
Q4 		$2.79M Hold
147,300
– – 0.09% 211
2017
Q3 		$2.59M Hold
147,300
– – 0.08% 200
2017
Q2 		$4.89M Sell
147,300
-5,200
-3% -$161K 0.15% 147
2017
Q1 		$4.89M Buy
+152,500
New +$5.2M 0.14% 153

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Hennessy Advisors Inc's TEVA Position: Q2 2025 in Review

Hennessy Advisors Inc sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 652,100 shares — an estimated $10M sold.

Hennessy Advisors Inc first reported a position in TEVA in Q1 2017 and held it in 8 quarters. The position peaked at $16M in Q4 2024. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Hennessy Advisors Inc reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Hennessy Advisors Inc sold 652,100 Teva Pharmaceuticals shares in Q2 2025, an estimated $10M.
  • Hennessy Advisors Inc first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • Hennessy Advisors Inc's Teva Pharmaceuticals position peaked at $16M in Q4 2024.
  • 540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Hennessy Advisors Inc's 13F filing for Q2 2025, filed 21 Jul 2025.